Advertisement

Topics

FDA Reports Further Support for Canagliflozin-Amputation Link

03:41 EDT 4 Aug 2017 | Medscape

The data are still insufficient to change prescribing recommendations, but they do suggest caution in prescribing canagliflozin for people at increased amputation risk.
Medscape Medical News

Original Article: FDA Reports Further Support for Canagliflozin-Amputation Link

NEXT ARTICLE

More From BioPortfolio on "FDA Reports Further Support for Canagliflozin-Amputation Link"

Quick Search
Advertisement